Avtor/Urednik | Šibanc, Branko; Tratar, Franci | |
Naslov | Prikaz racionalne uporabe protimikrobnih zdravil v Splošni bolnišnici Celje | |
Prevedeni naslov | The rational use of antimicrobials in the Celje general hospital | |
Tip | članek | |
Vir | Med Razgl | |
Vol. in št. | Letnik 38, št. Suppl 2 | |
Leto izdaje | 1999 | |
Obseg | str. 53-63 | |
Jezik | slo | |
Abstrakt | The main reason we decided to take a new approach towards antimicrobial treatment was the constant increase in the cost of antimicrobial drugs as well as the increase of the number of infections with multiple resistant microorganisms in the Celje General Hospital since 1995. For that purpose, in 1998 we came up with guidelines for antimicrobial treatment and an order form for ordering antimicrobials, which also enables us to have a constant control over the usage of antimicobilal drugs by the doctors and wards. The results show that in 1998, the defined daily dose per 100 bed days increased, contrary to the cost of the drugs, which became more cost-effective. The main reason is the increased use of penicillin antibiotics and first-and second generation cephalosporins generation, and the drop in use of third-generation cephalosporins and aminoglycosides, which was our main goal. | |
Izvleček | Naraščanje stroškov za antibiotična zdravila in števila okužb z večkratno odpornimi bakterijami v Splošni bolnišnici Celje nas je privedlo do novege pristopa k protimikrobnemu zdravljenju. V ta namen smo v letu 1998 pripravili Priporočila za protimikrobno zdravljenje in uvedli Obrazec za naročilo antibiotikov ter sprotno spremljanje porabe protimikrobnih učinkovin po oddelkih in po zdravnikih. Kot so pokazeli rezultati, se je poraba v dnevnih definiranih dozah na 100 bolnišničnooskrbnih dni (DDD/100 BOD) v letu 1998 povečala v primerjavi z letom 1997, vendar pa so bili dejanski stroški porabe manjši. To je predvsem posledica večje porabe penicilinskih antibiotikov in cefalosporinov 1. in 2. generacije ter zmanjšanja porabe cefalosporinov 3. generacije in aminoglikozidov, kar je bil tudi namen našega dela. | |
Deskriptorji | MEDICATION SYSTEMS, HOSPITAL DRUG UTILIZATION ANTIBIOTICS ECONOMICS, PHARMACEUTICAL DRUG RESISTANCE, MICROBIAL ECONOMICS, HOSPITAL |